53 results
SC 14D9
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
of the Merger;
the business reputation, capabilities and financial condition of Sobi, and the CTI Board’s perception that Sobi is willing to devote
SC14D9C
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
1:30pm
to or that is not reasonably likely to harm or disparage the Company or its Subsidiary or the reputation or goodwill of the Company or its Subsidiary and (ii) solely
8-K
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
to or that is not reasonably likely to harm or disparage the Company or its Subsidiary or the reputation or goodwill of the Company or its Subsidiary and (ii) solely
8-K
EX-10.2
CTIC
CTI BioPharma Corp
4 Mar 22
Departure of Directors or Certain Officers
5:04pm
of nolo contendre to, a crime which adversely affects the Company’s business or reputation, in each case as determined by the Board; and (vi
424B5
xlss7 8gf0u3
14 Feb 20
Prospectus supplement for primary offering
8:14am
424B5
70pi41fr
15 Nov 19
Prospectus supplement for primary offering
4:12pm
424B5
4q4rml
1 Nov 18
Prospectus supplement for primary offering
4:26pm